Ausgabe 1/2015
Inhalt (12 Artikel)
Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
Marc Evans, Sylvie Dejager, Anja Schweizer, James E. Foley
A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China
Huimei Hu, Monika Sawhney, Lizheng Shi, Shengnan Duan, Yunxian Yu, Zhihong Wu, Guixing Qiu, Hengjin Dong
Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial
Masato Odawara, Mika Yoshiki, Misako Sano, Izumi Hamada, Valentina Lukashevich, Wolfgang Kothny
Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials
Elizabeth S. Ommen, Lei Xu, Edward A. O’Neill, Barry J. Goldstein, Keith D. Kaufman, Samuel S. Engel
Liraglutide as Add-On Therapy to Insulin in Type 2 Diabetes Mellitus: A Retrospective, Observational Study From a Daily Clinical Practice Setting in Switzerland
Christof Lipowsky, Lisa Sze, Ina Krull, Michael Brändle
Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort
Shekhar Sehgal, Manish Khanolkar
Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin
Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano, Teresa Briones, Barnaby Hunt, William J. Valentine
A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
A. Brett Hauber, Kaan Tunceli, Jui-Chen Yang, Ira Gantz, Kimberly G. Brodovicz, Charles M. Alexander, Michael J. Davies, Larry Radican
Dialing Torque Preferences of People with Diabetes When Using Insulin Pens: A Pilot Study
Arnd Friedrichs, Mario Schmitz, Stefan Kamlot, Steffen Adler
Erratum to: Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
Sanjay Kalra
Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials
Elizabeth S. Ommen, Lei Xu, Edward A. O’Neill, Barry J. Goldstein, Keith D. Kaufman, Samuel S. Engel
Erratum to: Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort
Shekhar Sehgal, Manish Khanolkar